MONOTHERAPY
Clinical trials for MONOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new MONOTHERAPY trials appear
Sign up with your email to follow new studies for MONOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for NF1 skin tumors in early trial
Disease control Recruiting nowThis study tests a drug called mirdametinib in adults with neurofibromatosis type 1 (NF1) who have skin tumors called cutaneous neurofibromas. The goal is to find a safe dose and see if the drug can shrink these tumors. About 24 people will take the drug daily or on a three-week-…
Matched conditions: MONOTHERAPY
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a two-drug combo better tame prostate trouble?
Symptom relief Recruiting nowThis trial tests whether adding tadalafil to the standard drug tamsulosin improves urinary symptoms in men with an enlarged prostate (BPH). Ninety men over 45 with moderate-to-severe symptoms will receive either tamsulosin alone or tamsulosin plus a low (2.5 mg) or standard (5 mg…
Matched conditions: MONOTHERAPY
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC